PharmiWeb

Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics is proud to announce the launch of its comprehensive portfolio of ELISA Based Assays for vaccine ...
Yahoo Finance

Enzyme-Linked Immunosorbent Assay (ELISA) Market to Reach USD 3.63 Billion by 2033, Driven by Expanding Diagnostic Applications and Advancements in High-Throughput Testing ...

Austin, Oct. 24, 2025 (GLOBE NEWSWIRE) -- Enzyme-Linked Immunosorbent Assay (ELISA) Market Size & Growth Analysis According to SNS Insider, the global Enzyme-Linked Immunosorbent Assay (ELISA) Market ...
Yahoo Finance

Global Enzyme-Linked Immunosorbent Assay (ELISA) Market Research 2024-2029: ELISA as a Key Cost-effective Diagnostic Tool for Multiple Diagnostic Applications Fuels Adoption ...

Dublin, June 24, 2024 (GLOBE NEWSWIRE) -- The "Global Enzyme-Linked Immunosorbent Assay (ELISA) Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. The ...
insider.si.edu

The immunoassay handbook : theory and applications of ligand binding, ELISA, and related techniques / edited by David Wild ; associate editors, Rhys John [and others]

How to use this book / David Wild -- Immunoassay for beginners / David Wild -- Immunoassay performance measures / Chris Davies -- Principles of competitive and immunometric assays (including ELISA) / ...
Nasdaq

AXIM® Biotechnologies Develops ELISA-Based Neutralizing Antibody Diagnostic Test for COVID-19 and Applies for Patent; Company’s Fourth COVID-19 Test-Focused Patent Application

SAN DIEGO, Dec. 03, 2020 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or the “Company”), an international healthcare solutions company targeting oncological ...
Mena FN

Enzyme-Linked Immunosorbent Assay (ELISA) Market To Reach USD 3.63 Billion By 2033, Driven By Expanding Diagnostic Applications And Advancements In High-Throughput Testing SNS ...

(MENAFN- GlobeNewsWire - Nasdaq) SNS Insider projects the U.S. Enzyme-Linked Immunosorbent Assay (ELISA) Market to grow from USD 0.71 billion in 2025E to USD 1.10 billion by 2033, at a CAGR of 5.69%.